Silence Therapeutics (SLN) Research & Development: 2020-2025
Historic Research & Development for Silence Therapeutics (SLN) over the last 5 years, with Sep 2025 value amounting to $20.5 million.
- Silence Therapeutics' Research & Development rose 1.91% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.1 million, marking a year-over-year decrease of 43.20%. This contributed to the annual value of $67.9 million for FY2024, which is 19.22% up from last year.
- Per Silence Therapeutics' latest filing, its Research & Development stood at $20.5 million for Q3 2025, which was up 16.42% from $17.6 million recorded in Q2 2025.
- Silence Therapeutics' Research & Development's 5-year high stood at $97.0 million during Q4 2023, with a 5-year trough of -$10.3 billion in Q1 2021.
- For the 3-year period, Silence Therapeutics' Research & Development averaged around $16.5 million, with its median value being $17.6 million (2025).
- In the last 5 years, Silence Therapeutics' Research & Development crashed by 99.59% in 2021 and then spiked by 278.14% in 2024.
- Quarterly analysis of 5 years shows Silence Therapeutics' Research & Development stood at $73.2 million in 2021, then grew by 0.64% to $73.7 million in 2022, then soared by 31.60% to $97.0 million in 2023, then crashed by 77.23% to $22.1 million in 2024, then climbed by 1.91% to $20.5 million in 2025.
- Its Research & Development stands at $20.5 million for Q3 2025, versus $17.6 million for Q2 2025 and $20.8 million for Q1 2025.